OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Pulmonary Medicine is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Spirometry, computed tomography, comorbidities, oxygen therapy and other topics in chronic obstructive pulmonary disease and an update on silicosis	70
Bronchoscopic treatment of early-stage peripheral lung cancer	41
The persistent problem of persistent air-leaks: approach to management	33
Thoracic computed tomography in the progressive fibrotic phenotype	29
Cardiac sarcoidosis and neurosarcoidosis – multidisciplinary approach for diagnosis	27
Thoracic empyema: aetiology, diagnosis, treatment, and prevention	26
The role of PET in the management of sarcoidosis	26
Home monitoring in asthma: towards digital twins	25
The evolving role of radiological imaging in cystic fibrosis	25
Evolving nutritional needs, obesity, and overweight status in cystic fibrosis	24
Lung microbiome, gut–lung axis and chronic obstructive pulmonary disease	22
Improving care in lung cancer surgery: a review of quality measures and evolving standards	21
Digital outcome measures in pulmonary clinical trials	20
The different facets of sickle cell disease-related pulmonary hypertension	20
Direct oral anticoagulant use in special populations	18
Novel interventions on the tricuspid valve: how to consider the pulmonary circulation?	18
The justification for the progressive fibrotic phenotype	18
Genetic background of pulmonary (vascular) diseases – how much is written in the codes?	17
Group 2 pulmonary hypertension: from diagnosis to treatment	17
Bronchoscopic diagnosis of peripheral lung lesions	17
Disease-specific gaps within fungal respiratory tract infections: clinical features, diagnosis, and management in critically ill patients	17
The role of chest computed tomography in the evaluation and management of chronic obstructive pulmonary disease	16
Editorial introductions	16
Implementation of digital home monitoring and management of respiratory disease	16
Editorial: A future focus on cystic fibrosis in an era of uncertainty despite opportunity	16

Micro-RNA in obstructive sleep apnoea: biomarker of cardiovascular outcome?	16
Editorial introductions	14
Paediatric asthma - all that wheezes is not necessarily asthma - current diagnostic and management strategies	14
Asthma in pregnancy: a review of recent literature	14
Considerations and clinical management of infections in sarcoidosis	14
The future of clinical trials in idiopathic pulmonary fibrosis	13
Elexacaftor–tezacaftor–ivacaftor use after solid organ transplant	13
Co-morbid insomnia and sleep apnea (COMISA): recent research and future directions	13
Lung transplant referral considerations for individuals with cystic fibrosis	13
An update of palliative care in lung transplantation with a focus on symptoms, quality of life and functional outcomes	12
Household air pollution and respiratory health in Africa: persistent risk and unchanged health burdens	12
Casting light on the many facets of sarcoidosis	12
Sarcoidosis and frailty: recognizing factors that foster holistic resilience	11
Cystic fibrosis liver disease in the post-modulator era	11
Acute rejection post lung transplant	11
The modern landscape of fertility, pregnancy, and parenthood in people with cystic fibrosis	11
Tobacco treatment in the setting of lung cancer screening	11
Mechanisms relating to sleeping position to the endotypes of sleep disordered breathing	11
Progress for all: addressing disparities in sarcoidosis	11
The emerging role of inorganic elements as potential antigens in sarcoidosis	11
Management of patients with idiopathic pulmonary fibrosis and lung cancer: challenges in clinical practice	11
Therapeutic pipeline for individuals with cystic fibrosis with mutations nonresponsive to current cystic fibrosis transmembrane conductance regulator modulators	10
Utility of peak inspiratory flow measurement for dry powder inhaler use in chronic obstructive pulmonary disease	10
What causes cough in pulmonary fibrosis, and how should we treat it?	10
Digital inhalers for asthma management	10
Food for thought: optimal diet in patients with asthma and chronic obstructive pulmonary disease	10
Imaging in peripheral bronchoscopy	10
Home monitoring of coronavirus disease 2019 patients in different phases of disease	9
Chronic obstructive pulmonary disease risk assessment tools: is one better than the others?	9
Editorial: Silicosis, asbestos-related diseases, war-site exposures and a variety of topics in chronic obstructive pulmonary disease	9
Patterns of progression in non-IPF fibrotic interstitial lung disease	9
Editorial: Are we ready for prime time?	9
Mass gathering events and transmission of respiratory tract infections: updates pre and post COVID-19 lockdown	9
Novel insights in fibrotic pulmonary sarcoidosis	9
Obstructive lung diseases burden and COVID-19 in developing countries: a perspective	8
Neuropsychiatric adverse effects from CFTR modulators deserve a serious research effort	8
Role of extracorporeal membrane oxygenation and surgical embolectomy in acute pulmonary embolism	8
Epigenetics and aging: relevance for sleep medicine	8
Pediatric interventional bronchoscopy: from early limitations to achievable opportunities	8
Effectiveness and safety of coronavirus disease 2019 vaccines	8
Interventional pulmonology: reflection on the past, perfecting the present and innovating for the future	8
Infection control in cystic fibrosis: evolving perspectives and challenges	8
Telerehabilitation in pulmonary diseases	8
The association of preexisting severe asthma with COVID-19 outcomes	8
Chronic daily respiratory care needs in people with cystic fibrosis treated with highly effective cystic fibrosis transmembrane conductance regulator modulators	8
Exhaled breath analysis in interstitial lung disease	8
Altered pharmacology and toxicology during ageing: implications for lung disease	8
Multidisciplinary care in nonmalignant central airway obstruction	8
Transbronchial biopsy vs. bronchoalveolar lavage in interstitial lung disease	8
Editorial: ‘What is your occupation?’: historical snippets	8

Pulmonary rehabilitation in idiopathic pulmonary fibrosis	7
Adenotonsillectomy: the good, the bad and the unknown	7
Right ventricular assessment in pulmonary hypertension	7
Advancing bacteriophages as a treatment of antibiotic-resistant bacterial pulmonary infections	7
Rigid versus flexible bronchoscopy in interventional pulmonology: perspective from the master clinicians	7
The changing landscape of infections in the lung transplant recipient	7
Occupational exposures and sarcoidosis: current understanding and knowledge gaps	7
The current understanding and future directions for sputum microbiome profiling in chronic obstructive pulmonary disease	7
Telehealth and virtual health monitoring in cystic fibrosis	7
Prader–Willi syndrome: an update	6
Pre-chronic obstructive pulmonary disease: a pathophysiologic process or an opinion term?	6
Approach to the hospitalized patient with pulmonary arterial hypertension	6
Editorial introductions	6
Editorial introductions	6
Military deployment-related respiratory problems: an update	6
Shifting gears: the search for group 3 pulmonary hypertension treatment	6
Long-term safety, durability of response, cessation and switching of biologics	6
Pulmonary rehabilitation in a postcoronavirus disease 2019 world: feasibility, challenges, and solutions	6
Editorial introductions	6
Updates in the diagnosis and management of chronic thromboembolic disease	6
Pulmonary embolism work-up in chronic obstructive pulmonary disease exacerbations: what is the best strategy for clinicians?	6
Ergonomics in bronchoscopy	6
Advancements in airway stents: a comprehensive update	6
Examining the impact of air pollution, climate change, and social determinants of health on asthma and environmental justice	6
Pulmonary vascular disease in chronic lung diseases: cause or comorbidity?	6